loading
Schlusskurs vom Vortag:
$0.8672
Offen:
$0.8728
24-Stunden-Volumen:
1.39M
Relative Volume:
0.58
Marktkapitalisierung:
$132.63M
Einnahmen:
$400.57M
Nettoeinkommen (Verlust:
$9.21M
KGV:
20.49
EPS:
0.04
Netto-Cashflow:
$146.36M
1W Leistung:
+3.64%
1M Leistung:
+12.92%
6M Leistung:
-77.91%
1J Leistung:
-87.68%
1-Tages-Spanne:
Value
$0.8007
$0.90
1-Wochen-Bereich:
Value
$0.7449
$0.90
52-Wochen-Spanne:
Value
$0.5271
$7.105

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name
Firmenname
Ironwood Pharmaceuticals Inc
Name
Telefon
617-621-7722
Name
Adresse
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Name
Mitarbeiter
253
Name
Twitter
@ironwoodpharma
Name
Nächster Verdiensttermin
2025-02-21
Name
Neueste SEC-Einreichungen
Name
IRWD's Discussions on Twitter

Vergleichen Sie IRWD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
IRWD
Ironwood Pharmaceuticals Inc
0.8196 140.33M 400.57M 9.21M 146.36M 0.04
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
152.82 68.32B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.66 46.55B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.85 43.80B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.33 19.01B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
306.41 13.79B 2.99B 1.21B 1.13B 25.06

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-15 Herabstufung Jefferies Buy → Hold
2025-04-15 Herabstufung Wells Fargo Overweight → Equal Weight
2025-04-14 Herabstufung Citizens JMP Mkt Outperform → Mkt Perform
2024-09-09 Eingeleitet Leerink Partners Market Perform
2024-08-08 Herabstufung CapitalOne Overweight → Equal Weight
2024-01-17 Eingeleitet Craig Hallum Buy
2023-12-14 Eingeleitet Wells Fargo Overweight
2023-11-09 Eingeleitet Jefferies Buy
2023-09-28 Eingeleitet JMP Securities Mkt Outperform
2022-09-02 Eingeleitet CapitalOne Overweight
2022-04-22 Eingeleitet Piper Sandler Overweight
2020-09-30 Herabstufung Wells Fargo Overweight → Equal Weight
2020-06-17 Eingeleitet Northland Capital Outperform
2019-07-10 Fortgesetzt Credit Suisse Neutral
2019-03-27 Hochstufung Morgan Stanley Underweight → Equal-Weight
2019-02-25 Hochstufung H.C. Wainwright Sell → Neutral
2019-01-24 Hochstufung JP Morgan Underweight → Neutral
2018-11-07 Herabstufung Credit Suisse Outperform → Neutral
2018-11-07 Herabstufung JP Morgan Neutral → Underweight
2018-07-23 Eingeleitet H.C. Wainwright Sell
2018-05-09 Herabstufung Morgan Stanley Equal-Weight → Underweight
2018-01-05 Herabstufung BofA/Merrill Buy → Underperform
2017-12-06 Herabstufung Mizuho Buy → Neutral
2017-07-21 Herabstufung JP Morgan Overweight → Neutral
2017-05-03 Eingeleitet Wells Fargo Outperform
2017-04-07 Bestätigt Mizuho Buy
2017-02-22 Bestätigt Barclays Equal Weight
2016-11-04 Bestätigt Mizuho Buy
2016-10-24 Bestätigt Wedbush Neutral
2016-10-10 Bestätigt Mizuho Buy
2016-09-27 Bestätigt WallachBeth Hold
Alle ansehen

Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten

pulisher
Jul 24, 2025

Ironwood Pharmaceuticals Inc: Analyzing IRWD Stock Trends - investchronicle.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Ironwood Pharmaceuticals Inc. stock priceTriple-digit wealth increases - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Ironwood Pharmaceuticals Inc. stockHigh-yield market plays - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is Ironwood Pharmaceuticals Inc. a good long term investmentRapid portfolio appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Ironwood Pharmaceuticals Inc. Stock Analysis and ForecastFree Consultation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 17, 2025

How the Irritable Bowel Syndrome (IBS) Treatment Market Will - openPR.com

Jul 17, 2025
pulisher
Jul 15, 2025

How Ironwood Pharmaceuticals Inc. stock performs during market volatilityTop Gaining Low Risk Assets - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Ironwood Pharmaceuticals Inc. stock price move sharplyFast Moving Stock Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Ironwood Pharmaceuticals Inc. stock attracts strong analyst attentionHigh Confidence Trade Setups - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Endometriosis Pain Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine - The Globe and Mail

Jul 14, 2025
pulisher
Jul 14, 2025

Endometriosis Pain Pipeline 2025: FDA Updates, Therapy Innovations, And Clinical Trial Landscape Analysis By Delveinsight Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, Abbvie/Neurocrine - MenaFN

Jul 14, 2025
pulisher
Jul 10, 2025

Ironwood Pharmaceuticals appoints KPMG as new auditor, dismisses EY By Investing.com - Investing.com Nigeria

Jul 10, 2025
pulisher
Jul 10, 2025

Ironwood Pharmaceuticals appoints KPMG as new auditor, dismisses EY - Investing.com

Jul 10, 2025
pulisher
Jul 03, 2025

Investor Network: Ironwood Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Jul 03, 2025
pulisher
Jun 30, 2025

Ironwood Pharmaceuticals, Inc.(NasdaqGS: IRWD) added to Russell 3000E Index - MarketScreener

Jun 30, 2025
pulisher
Jun 25, 2025

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Held Back By Insufficient Growth Even After Shares Climb 28% - simplywall.st

Jun 25, 2025
pulisher
Jun 12, 2025

Ironwood Pharma Elects Directors at Annual Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 06, 2025

Why Is Ironwood (IRWD) Down 18.4% Since Last Earnings Report? - Yahoo Finance

Jun 06, 2025
pulisher
Jun 05, 2025

Ironwood Pharmaceuticals Inc (IRWD) Is A Good Stock To Invest In - Stocksregister

Jun 05, 2025
pulisher
May 29, 2025

Ameriprise Financial Inc. Trims Stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

May 29, 2025
pulisher
May 28, 2025

Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer - GlobeNewswire

May 28, 2025
pulisher
May 21, 2025

Ironwood Pharmaceuticals’ chief commercial officer sells $1,486 in stock By Investing.com - Investing.com India

May 21, 2025
pulisher
May 20, 2025

Ironwood Pharmaceuticals’ chief commercial officer sells $1,486 in stock - Investing.com Australia

May 20, 2025
pulisher
May 19, 2025

IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates - MSN

May 19, 2025
pulisher
May 16, 2025

Drug developer stocks fall as companies navigate clinical roadblocks - BioWorld MedTech

May 16, 2025

Finanzdaten der Ironwood Pharmaceuticals Inc-Aktie (IRWD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$70.93
price down icon 3.25%
$14.69
price down icon 2.20%
$9.35
price down icon 0.21%
drug_manufacturers_specialty_generic RDY
$14.71
price up icon 0.75%
$131.64
price down icon 1.51%
$306.41
price up icon 0.26%
Kapitalisierung:     |  Volumen (24h):